Cargando…
Atenolol vs. propranolol for the treatment of infantile haemangiomas: A systematic review and meta-analysis
Infantile haemangioma (IH) is a benign vascular tumour type that occurs in 3-10% of infants. In the present meta-analysis, previous studies comparing clinical outcomes, including the recovery rate and haemangioma activity score (HAS), adverse effects and relapse rates, were compared between patients...
Autores principales: | Liu, Zhuang, Wu, Changhua, Song, Dan, Wang, Liang, Li, Jing, Wang, Changfeng, Guo, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388287/ https://www.ncbi.nlm.nih.gov/pubmed/32742396 http://dx.doi.org/10.3892/etm.2020.8842 |
Ejemplares similares
-
Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma
por: HERMANS, Mireille M., et al.
Publicado: (2022) -
Cost-effectiveness of atenolol compared to propranolol as first-line treatment of infantile haemangioma: A pilot study
por: Wilson, Sasha, et al.
Publicado: (2022) -
A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas
por: Zhao, Ze-Liang, et al.
Publicado: (2021) -
Comparing the Effectiveness of Propranolol versus Atenolol in Inducing Clinical Clearance in the Treatment of Infantile Haemangioma: A Randomised Controlled Trial
por: Ashraf, Raihan, et al.
Publicado: (2023) -
Associations between short-term efficacy and clinical characteristics of infantile hemangioma treated by propranolol
por: Wu, Changhua, et al.
Publicado: (2019)